Archive for the ‘Drug Discovery’ Category
Anti-CRO sentiments: Outsourcing any knowledge-based element in drug discovery process can be a risky endeavour?
In a recent article in Drug Discovery Today Paul Branthwaite writes Outsourcing any knowledge-based element, large or small, on grounds of cost, without fully understanding what that actually means when you hand influence on critical issues over to an outside [...]
Reinventing the drug discovery wih synthetic biology
Andrew Hessel talks about his initiative the Pink Army Collective (PAC), a company inspired from principle and success of open source movements such as Apache and Linux. If it works PAC will bring fundamental change to the way drugs are [...]
Steering drug discovery efforts away from the flatland
Does high-throughput synthetic practices have failed the drug discovery efforts by steering them toward greater unsaturation leading to more flat aromatic compounds those may not be better complement to the target proteins? Yes at least that’s what Frank Lovering and [...]
Lowering Pharma firewalls: Just for Bioinformatics or Chemoinformatics also
Notion of pre-competitive collaboration has been in under experiment steadily for quite sometime now. Notable examples are the Airbus consortium of European aircraft manufacturers, the Sematech consortium of US semiconductor manufacturers, banks working together to launch Visa and Mastercard, our [...]
